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14. RT-PCR: RNA was extracted from pellets using an RNeasy
kit (Qiagen). Gene expression levels of collagen type II and type
X were assessed. Monolayer studies: hMSC and AHAC were
seeded in 6 well plates at a density of 2.5x105 per well and ex-
posed to BMP6 (500ng/ml), TGFb3 (10ng/ml), dexamethasone
(Dex 10-8M), Dex+TGFb3 and control base medium (DMEM
plus 10% Calf serum) for 4, 12, 24 and 72 hours. Western blot-
ting: Pellets and monolayer cells were lysed and loaded on 6%
Tris-Glycine gels (Invitrogen) and transferred to nitrocellulose.
Notch-1 antibody (rat anti human; bTAN20, Hybridoma Bank)
was used to detect the Notch-1 intracellular domain (NICD).
Secondary goat anti-rat HRP conjugated antibody (Santa Cruz)
was used to detect NICD. Mouse anti-human GAPDH was used
to ensure equal loading.
Results: Notch-1 during chondrogenesis: Reduction of Notch-1
was noted by day 4 of hMSC pellet culture and was almost
not detectable by day 8. Although, NICD protein levels returned
by day 14. Collagen type II and type X were detected by day
4 and continued to increase by day 14 (>100-fold compared
to monolayer). Notch-1 and prochondrogenic factors: Monolayer
culture of both AHAC and hMSC in the presence of TGFb3
led to a reduction in Notch-1 protein levels after 72 hours. No
detectable alteration in NICD was found with BMP6 or Dex.
Conclusions: Reduction of Notch-1 is required to allow chondro-
gensis and this preliminary data suggest that TGFb3 mediates
this process. The mechanism may due to increased proteosome
degradation or RNA instability. Notch-1 re-expression by day 14
parallels collagen type X up-regulation, which is consistent with
Notch’s dual role in mediating chondrogenesis and osteogenesis.
Understanding of transcription regulatory pathways mediated by
Notch will be needed if these cells are to be used successfully in
cell-based cartilage repair, where phenotype stability is essential.
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INTERLEUKIN-1 BETA AND INTERLEUKIN-6 DISTURB
THE ANTIOXIDANT ENZYME SYSTEM IN BOVINE
CHONDROCYTES: A POSSIBLE EXPLANATION FOR
OXIDATIVE STRESS GENERATION
M. Mathy-Hartert, L. Hogge, C. Sanchez, G. Deby-Dupont,
Y. Henrotin
University of Liège, Liège, Belgium
Purpose: Beside matrix metalloproteinases, reactive oxygen
species (ROS) are the main biochemical factors of cartilage
degradation. Numerous soluble factors, including interleukin (IL)-
1β and -6, stimulate ROS production by chondrocytes, and pre-
sumably induce an oxidative stress inside and in the vicinity
of the cells. To prevent ROS toxicity, chondrocytes possess a
well-coordinated antioxidant enzyme system mainly formed by
superoxide dismutases (SOD) and catalase (Cat). This work was
designed to assess the effects of IL-1β and IL-6 on the gene
expression and enzymatic activity of SOD and Cat in bovine
chondrocytes.
Methods: Bovine chondrocytes were cultured in monolayer for 4
hours to 11 days in the absence or in the presence of IL-1β (10-12
to 10-10 M) or IL-6 (10 to 100 ng/ml). To study signal transduction
pathway, inhibitors of mitogen-activated protein kinases (MAPK)
(PD98059, SB203580, SP600125) (5 to 20 μM) and NF-κB
inhibitor (BAY11-7082 (1 to 5 μM), MG-132 (0.1 to 10 μM))
were used. SOD and Cat enzymatic activities were evaluated
in cellular extract by using respectively the SOD Assay Kit-WST
(Dojindo Molecular Technologies) and the Amplex Red Catalase
Assay (Molecular Probes). Cu/Zn SOD, Mn SOD and Cat gene
expressions were quantified by reverse transcription of mRNA
followed by real time and quantitative polymerase chain reaction.
Results: SOD activity was dose and time dependently increased
by IL-1β, but not by IL-6. Further, IL-1β markedly enhanced
Mn SOD gene expression, but slightly decreased Cu/Zn SOD
gene expression. IL-1β-stimulated SOD enzymatic activity and
Mn SOD mRNA expression were inhibited by NF-κB inhibitors
but not by MAPK inhibitors. IL-6 did not significantly modified
SOD mRNA levels.
After 1 day of incubation, Cat gene expression was significantly
downregulated by IL-1β and IL-6. NF-kB and MAPK inhibitors did
not affect the IL-1β inhibitory effect. In parallel, after 5 days of
incubation, IL-6 and IL-1β decreased Cat activity.
Conclusions: We have demonstrated that IL-1β disturbs the
antioxidant enzyme system in chondrocytes. This cytokine in-
duces a rapid increase of Mn SOD production and a decrease of
catalase synthesis. The imbalance between SOD and catalase
could result in H2O2 accumulation, and generate intracellularly
an oxidative stress. To reinforce the antioxidant defences of
chondrocytes should be considered in the management of os-
teoarthritis.
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Purpose: In osteoarthritis (OA), articular chondrocytes change
phenotype to cells that express abnormal genes, including pro-
teolytic enzymes. It has been proposed that this represents
continued differentiation to the hypertrophic stage, inasmuch as
some hypertrophic markers (MMP-13 and type X collagen) are
expressed in OA. Alternatively, chondrocytes may be undergoing
de-differentiation to progenitor-like cells, then re-differentiation
into the new phenotype. To test this hypothesis, human artic-
ular cartilage of various OA grades was immunostained with
the following: c-Myc, a cellular proto-oncogene associated with
genomic instability, cell division or apoptosis; Nucleostemin, a
coordinator of self-renewal, expressed in stem cells, marrow
stromal and transformed cells; and Sox-9, which is expressed
early in chondrogenic differentiation and switched off in hyper-
trophic chondrocytes.
Methods: Human articular cartilage was obtained from femoral
heads after arthroplasty due to OA, fracture of the neck of femur
(#NOF) due to osteoporosis, or from a 14 year-old male (cerebral
palsy). Samples were graded for OA severity and immunocyto-
chemistry was carried out on paraffin sections. The staining
pattern of c-myc, nucleostemin, and Sox-9 was compared with
that of MMP-3, -9, -13 and ADAMTS-4 and -5. In Expression
of nucleostemin, c-myc and Sox-9 were also determined by
RT-PCR.
Results: The cartilage of the 14 year-old male showed no sign of
degradation and no immunostaining for the proteolytic enzymes
nor the markers of cellular change. The cartilage from #NOF
patients is near- normal (grade 0), but in the very superficial
zone there were already some flattened surface cells that were
immunopositive for c-myc and some of the proteolytic enzymes.
Often, such immuno-positive cells were found in an asymmetric
doublet with an immuno-negative cell, or two positive cells were
closely apposed, presumably because cell division had occurred.
However, nucleostemin and Sox-9 were still absent. In low-grade
OA, almost all cells in the upper region of proteoglycan loss
were immunopositive for c-myc and for all proteolytic enzymes.
Nucleostemin was noted in the nuclei of some chondrocytes,
with Sox-9 absent. In intermediate-grade OA, chondrocytes had
formed clones of 4-6 cells, all of which were positive for c-
myc, the proteolytic enzymes and for nucleostemin, now found
predominantly in the cytoplasm. In high-grade OA, with clones of
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up to 64 cells, Sox-9 was identified in all cells, along with c-Myc,
nucleostemin and the proteolytic enzymes. RT-PCR confirmed
expression of nucleostemin, c-myc and Sox-9.
Conclusions: Early expression of c-myc may indicate tempo-
rary genomic instability, i.e. a gene expression pattern in flux.
Because nucleostemin is found only in stem cells or cancer, the
presence in clonal chondrocytes is surprising and suggests that
chondrocytes undergo a de-differentiation to a progenitor-like in-
termediate. The re-activation of Sox-9 in late clones suggests
reversion to an earlier chondrocytic differentiation stage. Over-
all, the findings suggest that OA chondrocytes, because they
still retain some chondrocytic characteristics, display a com-
plicated and mixed phenotype, with degradative chondrocytes
arising from a progenitor-cell like intermediate stage, followed
by re-differentiation. At the same time, the observations do not
support the concept of continued differentiation to hypertrophic
chondrocytes.
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Purpose: Osteogenic Protein-1 (OP-1) is a potent growth fac-
tor for cartilage repair due to its pro-anabolic and anti-catabolic
activities. Our goal was to evaluate the role of OP-1 in human
cartilage homeostasis by gene array under conditions of lack
(inhibition of endogenous OP-1 gene by antisense oligos) or ex-
cess of OP-1 (stimulation with recombinant OP-1 [rhOP-1]). This
report is limited to the effect on anabolic genes (growth factors,
regulators of their signaling and matrix proteins) and catabolic
genes (inflammatory cytokines, their receptors, proteinases, and
transcription factors).
Methods: Human normal adult articular cartilage was obtained
from the ankle joints of 12 tissue donors, age 55-70 y/o, within
24 hours of death. After enzymatic digestion chondrocytes were
plated at high-density monolayers and either transfected with
OP-1 antisense oligos in the presence of lipofectin or treated
with rhOP-1 for 48 hours followed by RNA isolation. Gene ex-
pression profile was analyzed by HG-U133A gene chips from
Affimetrix. RNA within each treatment group was pooled from
all donors. Statistical analysis consisted of 1) analysis of differ-
entially expressed genes under single experimental condition in
comparison to control (up- or down-regulated in the presence
of OP-1 antisense or rhOP-1); 2) analysis of differentially regu-
lated genes by both treatments (OP-1 antisense and rhOP-1);
and 3) gene ontology. Selected gene array data were verified
experimentally in vitro or by real-time PCR.
Results: The results showed that the inhibition of endogenous
OP-1 led to down-regulation of a number of anabolic genes
among which were the members of the IGF-1 pathway: IGF-1
receptor (1.73-fold decrease), IGFBP-5 (1.9 fold) and IGFBP-7
(1.58-fold, P<0.01). In vitro validation experiments confirmed and
extended these findings: in chondrocytes treated with OP-1 anti-
sense expression of IGF-1 and its receptor was down-regulated,
while stimulation with rhOP-1 up-regulated their expression. This
in turn restored the response to IGF-1 diminished with aging
of human cartilage. Antisense inhibition of OP-1 reduced gene
expression of the TGF-β/BMP receptors and downstream signal-
ing/regulatory molecules. RhOP-1 inhibited BMP-2 (2.67-fold),
GDF-15 (3.04-fold), and activin (2.32-fold) expression. The fol-
lowing matrix proteins were regulated by OP-1: rhOP-1 induced
collagen type IX, COMP, and cadherin genes; while OP-1 an-
tisense reduced collagen type VI, versican, syndecan, bone
sialoprotein, and other genes. Among catabolic genes the most
affected by OP-1 were leukemia inhibitory factor (LIF), IL-6, IL-8,
IL-11, IL-1 and IL-6 receptors, NF-κB and AP-2. Inhibition of
OP-1 caused a 2-fold increase in their expression (p<0.001),
while treatment with rhOP-1 dramatically inhibited these genes:
LIF by 15.86-fold; IL-6 by 2-fold; IL-8 by 4.0-fold; and IL-11 by
8.69-fold (p<0.001). These changes were confirmed by real-time
PCR. In addition, OP-1 was not only able to reduce gene ex-
pression of autocrine cytokines, but counteracted their inhibitory
effect on proteoglycan synthesis. OP-1 also inhibited MMP-14
and TIMP-3, some caspases, ADAMs and ADAM-TSs.
Conclusions: The initial analysis of gene array data strongly
suggests a critical role of OP-1 in cartilage homeostasis. OP-1
regulates numerous metabolic pathways that are not only limited
to its anabolic function, but also to its anti-catabolic activity.
Understanding of OP-1 function in cartilage will provide strong
justification for the application of OP-1 protein as therapeutic
treatment for cartilage regeneration and repair.
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Purpose: Traumatic injury to a joint is known to increase the
risk of developing secondary osteoarthritis (OA). Various in-vitro
models of injurious loading have been employed to simulate the
effects of joint injury on articular cartilage. The aim of this study
was to compare two of the most common types of pathological
loading models; a single, fast impact load and a slow, severe
load.
Methods: Full depth, circular explants (5 mm diameter) of artic-
ular cartilage were removed from the subchondral bone of two
human femoral heads using a cork borer and scalpel and cul-
tured for 24 h to equilibrate. Explants (n = 24 from each femoral
head), were matched for initial thickness into 3 groups. One
group was subjected to a single, fast impact load using a 500 g
mass dropped from a height of 25 mm in a drop tower. The mean
maximum strain was found and the second group subjected to
loading to the same strain in an Instron materials testing machine
at the fastest available cross-head speed of 40 mm s-1. The third
group served as a control. The modulus was determined from
the maximum gradient of the stress/strain curve for each load.
All explants were then cultured for either 24 h or 72 h. Chondro-
cyte viability was determined in transverse sections (∼500 μm)
using the fluorescein diacetate/propidium iodide method. Frozen
cartilage sections (8 μm) were used to evaluate apoptotic cell
death (TUNEL), matrix damage (haematoxylin and eosin stain),
and glycosaminoglycan (GAG) distribution (toluidine blue stain).
Results: The peak stress of the fast, impact load was 21.7 ±
0.4 MPa and was reached after 1.5 ± 0.1 ms giving a peak
modulus for cartilage of 87.8 ± 13.0 MPa. In comparison, for
slow, severe loading, the peak stress was 0.8 ± 0.2 MPa, with a
duration of 42.4 ± 1.6 ms and a peak modulus of 4.5 ± 1.4 MPa.
Macroscopically, the explants subjected to slow, severe loading
were considerably more damaged than those that were fast im-
pacted; becoming flattened and elliptical in shape with extensive
fissuring. The number of dead cells was also greater with this
type of loading and, after 72 h, only a few viable cells were visible
in the superficial layer. Slow load resulted in about 70% of chon-
drocytes becoming apoptotic by 24 h, and this was unchanged
after 72 h. In contrast, impact loaded explants only had about
10% apoptotic cells (similar to unloaded controls) at 24 h but this
